Abstract:The electronic structures, geometric structures and some molecular properties (generalized structural indexes) of quinazoline derivatives were computed by using density functional theory and molecular mechanism methods to investigate the quantitative structure-activity relationship (QSAR) of the inhibitory activity toward the nuclear factor kappa B. Via a stepwise regression analysis, some main factors affecting the activity of the compounds were factored out, and then the QSAR equation was effectively established. It was found that the hydrophobic parameter of the substituent on ring D is the main factor affecting the inhibitory activity of the compound. The analysis indicated, the larger the hydrophobic parameter, the higher the inhibitory activity of the compound. In addition, the net charge of the first atom and the stereoscopic parameter (MR1) of the substituent R-1 on A-ring as well as the net charge of C-3 are closely correlated with the inhibitory activity of the compound. In order to test the predicted results of the QSAR equation, we adopted the '' leave one out '' cross-validation, and found that the calculated coefficient q(2) was rather high and the predicted results were both accurate and reliable. Such facts show that the obtained equation has great predictive ability. The above results can offer an important theoretical guide in the search for new quinazoline derivatives with higher inhibitory activity, and in an analysis of their action mechanisms. It is noteworthy that this scheme would be very advantageous in factoring out precursors with excellent inhibitory activity via the computer ADDIT molecule-design, since all parameters in the QSAR equation are computable and controllable.

Quantitative Structure-Activity Relationships (qsar): Studies of Inhibitors of Tyrosine Kinase

3D-QSAR and Molecular Docking Studies of Pyrimidine-based EGFR Inhibitors

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

QSAR Studies on 4-Anilino-3-quinolinecarbonitriles As Src Kinase Inhibitors Using Robust PCA and Both Linear and Nonlinear Models

Structure-based QSAR, Molecule Design and Bioassays of Protease-Activated Receptor 1 Inhibitors

Prediction of Inhibitory Activity of Epidermal Growth Factor Receptor Inhibitors Using Grid Search-Projection Pursuit Regression Method

Qsar Studies on Aminothiazole Derivatives As Aurora A Kinase Inhibitors

3D-QSAR and Docking Study on 3-Benzimidazol-2-ylhydroquinolin-2-one Derivatives As VEGFR-2 Tyrosine Kinase Inhibitors

Quantitative Structure-Activity Relationship of 2-Alkyl-4-(biphenylylmethoxy) Pyridine Derivatives with AT1 Receptor Antagonistic Activity

Quantitative Structure-Activity Relationship Of Quinazoline Derivatives With The Inhibitory Activity Toward Nf-Kappa B

Studies on the Inhibitory Models of Pyrazoline Derivatives As EGFR Kinase Inhibitors by 3D-QSAR and Molecular Docking

D-QSAR studies on pyrimidine analogues as cyclin-dependent kinase 1 inhibitors

Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110alpha inhibitors.

Enhanced Replacement Method‐based Quantitative Structure–Activity Relationship Modeling and Support Vector Machine Classification of 4‐anilino‐3‐quinolinecarbonitriles As Src Kinase Inhibitors

3D QSAR Studies on a Series of Potent and High Selective Inhibitors for Three Kinases of RTK Family

Receptor and ligand-based 3D-QSAR study on a series of pyrazines/pyrrolidylquinazolines as inhibitors of PDE10A enzyme

Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.

Studies on molecular mechanism between SHP2 and pyridine derivatives by 3D-QSAR, molecular docking and MD simulations

Validated Quantitative Structure–activity Relationship Analysis of a Series of 2-Aminothiazole Based P56lck Inhibitors

Three-Dimensional Quantitative Structure-Activity Relationship of 4,5,6,7-Tetrahydrothienopyridines Analogues As Glucose-6-Phosphatase Inhibitors

Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110α inhibitors